Concepedia

Ana Vuletić

AV

20

Publications

580

Citations

16

H-Index

2007

Active since

Affiliations

Oncology Institute of Vojvodina(Current)

University of Kragujevac

University of Belgrade

Institute for Biological Research “Siniša Stanković”

Ana Vuletić is an author at Oncology Institute of Vojvodina specializing in medicine, immunology, and cell biology.

ORCID

Top concepts

Publications per year

2007–2023

20

Publications

20

Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients

Gordana Konjević, Katarina Mirjačić Martinović, Ana Vuletić et al. · Clinical & Experimental Metastasis · 2007 · 91 citations

, , +6

Decreased CD161 activating and increased CD158a inhibitory receptor expression on NK cells underlies impaired NK cell cytotoxicity in patients with multiple myeloma

Gordana Konjević, Ana Vuletić, Katarina Mirjačić Martinović et al. · Journal of Clinical Pathology · 2016 · 51 citations

In-vitro IL-2 or IFN-α-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients

Gordana Konjević, Katarina Mirjačić Martinović, Ana Vuletić et al. · Melanoma Research · 2010 · 40 citations

Evaluation of cytokine expression and circulating immune cell subsets as potential parameters of acute radiation toxicity in prostate cancer patients

Tatjana Stanojković, Ivana Z. Matić, Nina Petrović et al. · Scientific Reports · 2020 · 40 citations · Full text

Antiproliferative Effect of 13-cis-Retinoic Acid is Associated with Granulocyte Differentiation and Decrease in Cyclin B1 and Bcl-2 Protein Levels in G0/G1 Arrested HL-60 Cells

Ana Vuletić, Gordana Konjević, Desanka Milanović et al. · Pathology & Oncology Research · 2010 · 37 citations

, , +10

Rows per page

1–5 of 20